Ceapro Inc. - Financial and Strategic Analysis Review
| Publication Date | June 2009 |
|---|---|
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 17 |
| ISBN Number | not applicable |
| Product Code | GMD09371 |
Buy this product or for assistance call +44 20 7060 7474
Summary
Ceapro Inc. - Financial and Strategic Analysis Review
Ceapro Inc. (Ceapro) is a Canadian growth-stage biotechnology company. It is principally engaged in the research, production and commercialization of natural and organic products for medical, cosmetic, and animal health. The company operates along with its five subsidiaries. It uses technology and natural, renewable resources for its products. Ceapro is principally focused on developing a wide range of active ingredients and formulations to enhance the human and animal health. The company operates through three product categories; namely, active ingredient, veterinary therapeutic products and diabetes screening.
Global Markets Direct's Ceapro Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Ceapro Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Scope
- Provides key company information for business intelligence needs.
- The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers' businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers - with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company's financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Content
- List of Tables
- List of Figures
- Ceapro Inc. - Key Facts
- Ceapro Inc. - Business Description
- Ceapro Inc. - Major Products and Services
- Ceapro Inc. - History
- Ceapro Inc. - SWOT Analysis
- SWOT Analysis - Overview
- Ceapro Inc. - Strengths
- Strength - Increase in Revenues
- Strength - Focused Research and Development Activities
- Strength - Licensing and Partnerships
- Ceapro Inc. - Weaknesses
- Weakness - Limited Distribution Network
- Weakness - Liquidity & Interest Rate Risk
- Ceapro Inc. - Opportunities
- Opportunity - Growing Nutraceuticals Market
- Opportunity - Expansion in South Korean Markets
- Ceapro Inc. - Threats
- Threat - Impact of Financial Crisis
- Threat - Tightening of FDA's Regulatory Oversight
- Threat - Foreign Currency Fluctuations
- Ceapro Inc. - Key Competitors
- Ceapro Inc. - Key Employees
- Ceapro Inc. - Key Employee Biographies
- Ceapro Inc. - Company Statement
- Ceapro Inc. - Locations And Subsidiaries
- Head Office
- Ceapro Inc. - Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Appendix
- Methodology
- Ratio Definitions
- About Global Markets Direct
- Contact Us
- Disclaimer
- List of Tables
- Ceapro Inc., Key Facts
- Ceapro Inc., Major Products and Services
- Ceapro Inc., History
- Ceapro Inc., Key Employees
- Ceapro Inc., Key Employee Biographies
- Ceapro Inc., Ratios based on current share price
- Ceapro Inc., Annual Ratios
- Ceapro Inc., Interim Ratios
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Ceapro Inc., Ratio Charts
Delivery Details
PDF:Delivered by email usually within 12 to 24 UK business hours.
Product features / use
| Scope | Expert Insight/Opinion | ![]() |
| Profiles | In-depth Company Insight | ![]() |
| Features | Contains SWOT Analysis | ![]() |
Related Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories












